Wiffen S J, Hodge D O, Nelson L R, Bruner W E, Bourne W M
Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota 55905, USA.
Cornea. 1997 Mar;16(2):169-76.
The purpose of this study was to relate lysosomal enzyme activities in corneal storage media to the outcome of the transplanted corneas.
Corneal storage media from 358 transplanted corneas were frozen at -70 degrees C and kept for enzyme analysis. Corneas were stored in K-Sol (28), CSM (35), Dexsol (80), Index medium (five), Optisol (158), and Optisol GS (52). Activities of alpha-D-mannosidase, beta-glucuronidase, alpha-glucosidase, and N-acetyl-beta-glucosaminidase were assayed fluorometrically. Mayo Clinic records were examined for donor information, including cause of death and 2-month graft follow-up data.
For all corneas, there was a low but significant correlation between activities of each enzyme and storage time (rs = 0.13-0.35; p = 0.02-0.0001), and donor age (rs = -0.14 to -0.23; p = 0.009-0.0001). There was no significant correlation of enzyme activity with 2-month endothelial cell density, structure, cell loss, or corneal thickness. Enzyme activities for four primary donor failures and six grafts with > 65% 2-month endothelial cell loss were not significantly different from those for the rest of the transplanted corneas. Enzyme activities were higher for corneas from donors with renal failure but not from those with diabetes mellitus. There was no significant difference in graft outcome for different cause-of-death groups.
The activities of lysosomal enzymes released into corneal storage media are not useful as predictors of graft outcome.
本研究旨在探讨角膜保存介质中的溶酶体酶活性与移植角膜预后之间的关系。
将358只移植角膜的保存介质在-70℃下冷冻,用于酶分析。角膜分别保存在K-Sol(28只)、CSM(35只)、Dexsol(80只)、Index培养基(5只)、Optisol(158只)和Optisol GS(52只)中。采用荧光法检测α-D-甘露糖苷酶、β-葡萄糖醛酸酶、α-葡萄糖苷酶和N-乙酰-β-葡萄糖胺酶的活性。查阅梅奥诊所记录以获取供体信息,包括死亡原因和移植后2个月的随访数据。
对于所有角膜,每种酶的活性与保存时间(rs = 0.13 - 0.35;p = 0.02 - 0.0001)以及供体年龄(rs = -0.14至-0.23;p = 0.009 - 0.0001)之间存在低但显著的相关性。酶活性与移植后2个月的内皮细胞密度、结构、细胞丢失或角膜厚度无显著相关性。4例原发性供体失败和6例移植后2个月内皮细胞丢失>65%的移植角膜的酶活性与其余移植角膜的酶活性无显著差异。肾衰竭供体的角膜酶活性较高,但糖尿病供体的角膜酶活性无此情况。不同死亡原因组的移植预后无显著差异。
释放到角膜保存介质中的溶酶体酶活性不能作为移植预后的预测指标。